There has been a shakeup in markets since Donald Trump’s election, and investors have been positioning their portfolios to ...
When a chief executive unveils a big merger, the fretting begins. Concerns about a repeat of disasters like AOL-Time Warner ...
CrowdStrike is back near highs despite crashing in July. Why Raymond James' David Cox calls it "immediately suspicious." ...
Stocks have gotten off to a mixed start in 2025, but a third straight year of gains isn’t out of the question.
Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total ...